In vivo CAR T-cell generation: delivery platforms, clinical progress, and translational barriers

Tianqun Huo, Hongping Yao, Ziyan Kong

Open source

DOI
10.3389/fimmu.2026.1927594
Published
2026-09-04
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1927594,
  title = {In vivo CAR T-cell generation: delivery platforms, clinical progress, and translational barriers},
  author = {Tianqun Huo and Hongping Yao and Ziyan Kong},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1927594},
  url = {https://doi.org/10.3389/fimmu.2026.1927594}
}

RIS

TY  - JOUR
TI  - In vivo CAR T-cell generation: delivery platforms, clinical progress, and translational barriers
AU  - Tianqun Huo
AU  - Hongping Yao
AU  - Ziyan Kong
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1927594
UR  - https://doi.org/10.3389/fimmu.2026.1927594
ER  - 

APA

Huo, T., Yao, H., & Kong, Z. (2026). In vivo CAR T-cell generation: delivery platforms, clinical progress, and translational barriers. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1927594

Source records